Fentanyl-induced transformations in composition of lipid droplets in central nervous system cells revealed by ramanomics
- PMID: 40398506
- PMCID: PMC12221884
- DOI: 10.1016/j.jlr.2025.100827
Fentanyl-induced transformations in composition of lipid droplets in central nervous system cells revealed by ramanomics
Abstract
Quantitative characterization of the transformations of subcellular molecular environment in response to fentanyl exposure in human microglia and astrocytes is warranted to provide insight into the regulation of neuroinflammatory responses and neural survival in the scenario of opiate drug addiction. Cytoplasmic lipid droplets (LD) act as depot for exogeneous hydrophobic molecules, such as fentanyl, which can lead to increased drug accumulation and alteration of their metabolism. In the present work, we have used an emerging Ramanomics technique that combines quantitative microlipid droplets -Raman spectrometry with biomolecular component analysis to unravel fentanyl induced changes in concentrations of phospholipids, sterols, glycogen, sphingomyelin, phosphocholine as well as RNA and proteins, in the LDs of microglia and astrocytes. The clinical relevance of these findings includes the potential to advance understanding of fentanyl's impact on the central nervous system at a molecular level. The observed alterations in lipid droplet composition, including changes in phospholipids, cholesterol esters, and glycogen accumulation, suggest that fentanyl overdose disrupts cellular homeostasis in microglia and astrocytes. This disruption could contribute to neuroinflammatory responses and impaired neural function, which are critical factors in opioid addiction and withdrawal. By utilizing Ramanomics as a noninvasive, real-time analytical tool, we can better assess fentanyl-induced cellular changes, paving the way for improved diagnostic assays and therapeutic strategies for opioid addiction and overdose treatment.
Keywords: cholesterol; kinetics; lipid/chemistry; lipids; phospholipids.
Copyright © 2025 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.
Figures




Similar articles
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Inhibition of CD36 ameliorates mouse spinal cord injury by accelerating microglial lipophagy.Acta Pharmacol Sin. 2025 May;46(5):1205-1220. doi: 10.1038/s41401-024-01463-w. Epub 2025 Jan 29. Acta Pharmacol Sin. 2025. PMID: 39880928
-
APOE4 alters the lipid droplet proteome and modulates droplet dynamics.bioRxiv [Preprint]. 2024 Dec 20:2024.12.16.628710. doi: 10.1101/2024.12.16.628710. bioRxiv. 2024. Update in: Neurobiol Dis. 2025 Aug;212:106983. doi: 10.1016/j.nbd.2025.106983. PMID: 39763832 Free PMC article. Updated. Preprint.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.Cochrane Database Syst Rev. 2014 May 29;2014(5):CD011056. doi: 10.1002/14651858.CD011056.pub2. Cochrane Database Syst Rev. 2014. PMID: 24874470 Free PMC article.
References
-
- Strang J., Volkow N.D., Degenhardt L., Hickman M., Johnson K., Koob G.F., et al. Opioid use disorder. Nat. Rev. Dis. Primers. 2020;6:3. - PubMed
-
- Hull M.J., Juhascik M., Mazur F., Flomenbaum M.A., Behonick G.S. Fatalities associated with fentanyl and co-administered cocaine or opiates. J. Forensic. Sci. 2007;52:1383–1388. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials